img

Global Chronic Myeloid Leukemia Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chronic Myeloid Leukemia Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
Chronic Myeloid Leukemia Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chronic Myeloid Leukemia Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chronic Myeloid Leukemia Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chronic Myeloid Leukemia Treatment key manufacturers include Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.) and Lupin, etc. Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG are top 3 players and held % sales share in total in 2022.
Chronic Myeloid Leukemia Treatment can be divided into Tablet, Solution and Capsule,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Chronic Myeloid Leukemia Treatment is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Chronic Myeloid Leukemia Treatment industry development. In 2022, global % sales of Chronic Myeloid Leukemia Treatment went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Myeloid Leukemia Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd.
Novartis AG
Bristol-Myers Squibb Company
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Innovent Biologics, Inc.
Viatris Inc. (Mylan N.V.)
Lupin
IL-YANG PHARM CO. LTD.
Million Health Pharmaceuticals
Celon Labs
Segment by Type
Tablet
Solution
Capsule

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chronic Myeloid Leukemia Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chronic Myeloid Leukemia Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chronic Myeloid Leukemia Treatment industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Chronic Myeloid Leukemia Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chronic Myeloid Leukemia Treatment introduction, etc. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chronic Myeloid Leukemia Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Chronic Myeloid Leukemia Treatment Market Overview
1.1 Chronic Myeloid Leukemia Treatment Product Overview
1.2 Chronic Myeloid Leukemia Treatment Market Segment by Type
1.2.1 Tablet
1.2.2 Solution
1.2.3 Capsule
1.3 Global Chronic Myeloid Leukemia Treatment Market Size by Type
1.3.1 Global Chronic Myeloid Leukemia Treatment Market Size Overview by Type (2024-2034)
1.3.2 Global Chronic Myeloid Leukemia Treatment Historic Market Size Review by Type (2024-2024)
1.3.3 Global Chronic Myeloid Leukemia Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chronic Myeloid Leukemia Treatment Sales Breakdown by Type (2024-2024)
1.4.2 Europe Chronic Myeloid Leukemia Treatment Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Chronic Myeloid Leukemia Treatment Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Breakdown by Type (2024-2024)
2 Global Chronic Myeloid Leukemia Treatment Market Competition by Company
2.1 Global Top Players by Chronic Myeloid Leukemia Treatment Sales (2024-2024)
2.2 Global Top Players by Chronic Myeloid Leukemia Treatment Revenue (2024-2024)
2.3 Global Top Players by Chronic Myeloid Leukemia Treatment Price (2024-2024)
2.4 Global Top Manufacturers Chronic Myeloid Leukemia Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chronic Myeloid Leukemia Treatment Market Competitive Situation and Trends
2.5.1 Chronic Myeloid Leukemia Treatment Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chronic Myeloid Leukemia Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Chronic Myeloid Leukemia Treatment Market
2.8 Key Manufacturers Chronic Myeloid Leukemia Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chronic Myeloid Leukemia Treatment Status and Outlook by Region
3.1 Global Chronic Myeloid Leukemia Treatment Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Chronic Myeloid Leukemia Treatment Historic Market Size by Region
3.2.1 Global Chronic Myeloid Leukemia Treatment Sales in Volume by Region (2024-2024)
3.2.2 Global Chronic Myeloid Leukemia Treatment Sales in Value by Region (2024-2024)
3.2.3 Global Chronic Myeloid Leukemia Treatment Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Chronic Myeloid Leukemia Treatment Forecasted Market Size by Region
3.3.1 Global Chronic Myeloid Leukemia Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Chronic Myeloid Leukemia Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Chronic Myeloid Leukemia Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Chronic Myeloid Leukemia Treatment by Application
4.1 Chronic Myeloid Leukemia Treatment Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Chronic Myeloid Leukemia Treatment Market Size by Application
4.2.1 Global Chronic Myeloid Leukemia Treatment Market Size Overview by Application (2024-2034)
4.2.2 Global Chronic Myeloid Leukemia Treatment Historic Market Size Review by Application (2024-2024)
4.2.3 Global Chronic Myeloid Leukemia Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chronic Myeloid Leukemia Treatment Sales Breakdown by Application (2024-2024)
4.3.2 Europe Chronic Myeloid Leukemia Treatment Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Chronic Myeloid Leukemia Treatment Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Breakdown by Application (2024-2024)
5 North America Chronic Myeloid Leukemia Treatment by Country
5.1 North America Chronic Myeloid Leukemia Treatment Historic Market Size by Country
5.1.1 North America Chronic Myeloid Leukemia Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2024)
5.1.3 North America Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2024)
5.2 North America Chronic Myeloid Leukemia Treatment Forecasted Market Size by Country
5.2.1 North America Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2034)
6 Europe Chronic Myeloid Leukemia Treatment by Country
6.1 Europe Chronic Myeloid Leukemia Treatment Historic Market Size by Country
6.1.1 Europe Chronic Myeloid Leukemia Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2024)
6.1.3 Europe Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2024)
6.2 Europe Chronic Myeloid Leukemia Treatment Forecasted Market Size by Country
6.2.1 Europe Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Chronic Myeloid Leukemia Treatment by Region
7.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Chronic Myeloid Leukemia Treatment Sales in Value by Region (2024-2034)
8 Latin America Chronic Myeloid Leukemia Treatment by Country
8.1 Latin America Chronic Myeloid Leukemia Treatment Historic Market Size by Country
8.1.1 Latin America Chronic Myeloid Leukemia Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2024)
8.1.3 Latin America Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2024)
8.2 Latin America Chronic Myeloid Leukemia Treatment Forecasted Market Size by Country
8.2.1 Latin America Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Chronic Myeloid Leukemia Treatment by Country
9.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Chronic Myeloid Leukemia Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Teva Pharmaceutical Industries Ltd
10.1.1 Teva Pharmaceutical Industries Ltd Company Information
10.1.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Products Offered
10.1.5 Teva Pharmaceutical Industries Ltd Recent Development
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 F. Hoffmann-La Roche Ltd. Company Information
10.2.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Products Offered
10.2.5 F. Hoffmann-La Roche Ltd. Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Products Offered
10.3.5 Novartis AG Recent Development
10.4 Bristol-Myers Squibb Company
10.4.1 Bristol-Myers Squibb Company Company Information
10.4.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Products Offered
10.4.5 Bristol-Myers Squibb Company Recent Development
10.5 Pfizer Inc.
10.5.1 Pfizer Inc. Company Information
10.5.2 Pfizer Inc. Introduction and Business Overview
10.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Products Offered
10.5.5 Pfizer Inc. Recent Development
10.6 Takeda Pharmaceutical Company Limited
10.6.1 Takeda Pharmaceutical Company Limited Company Information
10.6.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Products Offered
10.6.5 Takeda Pharmaceutical Company Limited Recent Development
10.7 Innovent Biologics, Inc.
10.7.1 Innovent Biologics, Inc. Company Information
10.7.2 Innovent Biologics, Inc. Introduction and Business Overview
10.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Products Offered
10.7.5 Innovent Biologics, Inc. Recent Development
10.8 Viatris Inc. (Mylan N.V.)
10.8.1 Viatris Inc. (Mylan N.V.) Company Information
10.8.2 Viatris Inc. (Mylan N.V.) Introduction and Business Overview
10.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Products Offered
10.8.5 Viatris Inc. (Mylan N.V.) Recent Development
10.9 Lupin
10.9.1 Lupin Company Information
10.9.2 Lupin Introduction and Business Overview
10.9.3 Lupin Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Lupin Chronic Myeloid Leukemia Treatment Products Offered
10.9.5 Lupin Recent Development
10.10 IL-YANG PHARM CO. LTD.
10.10.1 IL-YANG PHARM CO. LTD. Company Information
10.10.2 IL-YANG PHARM CO. LTD. Introduction and Business Overview
10.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Products Offered
10.10.5 IL-YANG PHARM CO. LTD. Recent Development
10.11 Million Health Pharmaceuticals
10.11.1 Million Health Pharmaceuticals Company Information
10.11.2 Million Health Pharmaceuticals Introduction and Business Overview
10.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Products Offered
10.11.5 Million Health Pharmaceuticals Recent Development
10.12 Celon Labs
10.12.1 Celon Labs Company Information
10.12.2 Celon Labs Introduction and Business Overview
10.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Products Offered
10.12.5 Celon Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chronic Myeloid Leukemia Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chronic Myeloid Leukemia Treatment Industrial Chain Analysis
11.4 Chronic Myeloid Leukemia Treatment Market Dynamics
11.4.1 Chronic Myeloid Leukemia Treatment Industry Trends
11.4.2 Chronic Myeloid Leukemia Treatment Market Drivers
11.4.3 Chronic Myeloid Leukemia Treatment Market Challenges
11.4.4 Chronic Myeloid Leukemia Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chronic Myeloid Leukemia Treatment Distributors
12.3 Chronic Myeloid Leukemia Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablet
Table 2. Major Company of Solution
Table 3. Major Company of Capsule
Table 4. Global Chronic Myeloid Leukemia Treatment Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (K Units)
Table 6. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US& Million)
Table 8. Global Chronic Myeloid Leukemia Treatment Market Share in Value by Type (2024-2024)
Table 9. Global Chronic Myeloid Leukemia Treatment Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2034) & (K Units)
Table 11. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type (2024-2034)
Table 14. Global Chronic Myeloid Leukemia Treatment Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (K Units)
Table 16. North America Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2024-2024)
Table 18. Europe Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2024-2024)
Table 22. Latin America Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Chronic Myeloid Leukemia Treatment Sales by Company (2024-2024) & (K Units)
Table 26. Global Chronic Myeloid Leukemia Treatment Sales Share by Company (2024-2024)
Table 27. Global Chronic Myeloid Leukemia Treatment Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Chronic Myeloid Leukemia Treatment Revenue Share by Company (2024-2024)
Table 29. Global Market Chronic Myeloid Leukemia Treatment Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Chronic Myeloid Leukemia Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Chronic Myeloid Leukemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment as of 2022)
Table 33. Date of Key Manufacturers Enter into Chronic Myeloid Leukemia Treatment Market
Table 34. Key Manufacturers Chronic Myeloid Leukemia Treatment Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Chronic Myeloid Leukemia Treatment Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Chronic Myeloid Leukemia Treatment Sales by Region (2024-2024) & (K Units)
Table 38. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Chronic Myeloid Leukemia Treatment Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Region (2024-2024)
Table 41. Global Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (K Units)
Table 43. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Region (2024-2034)
Table 46. Global Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Chronic Myeloid Leukemia Treatment Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (K Units)
Table 49. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application (2024-2024)
Table 52. Global Chronic Myeloid Leukemia Treatment Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2034) & (K Units)
Table 54. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application (2024-2034)
Table 57. Global Chronic Myeloid Leukemia Treatment Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) (K Units)
Table 59. North America Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) (K Units)
Table 61. Europe Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) (K Units)
Table 65. Latin America Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (K Units)
Table 69. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2024)
Table 72. North America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 73. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (K Units)
Table 77. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 81. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Country (2024-2034)
Table 108. Teva Pharmaceutical Industries Ltd Company Information
Table 109. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 110. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product
Table 112. Teva Pharmaceutical Industries Ltd Recent Development
Table 113. F. Hoffmann-La Roche Ltd. Company Information
Table 114. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 115. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product
Table 117. F. Hoffmann-La Roche Ltd. Recent Development
Table 118. Novartis AG Company Information
Table 119. Novartis AG Introduction and Business Overview
Table 120. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Novartis AG Chronic Myeloid Leukemia Treatment Product
Table 122. Novartis AG Recent Development
Table 123. Bristol-Myers Squibb Company Company Information
Table 124. Bristol-Myers Squibb Company Introduction and Business Overview
Table 125. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product
Table 127. Bristol-Myers Squibb Company Recent Development
Table 128. Pfizer Inc. Company Information
Table 129. Pfizer Inc. Introduction and Business Overview
Table 130. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product
Table 132. Pfizer Inc. Recent Development
Table 133. Takeda Pharmaceutical Company Limited Company Information
Table 134. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 135. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product
Table 137. Takeda Pharmaceutical Company Limited Recent Development
Table 138. Innovent Biologics, Inc. Company Information
Table 139. Innovent Biologics, Inc. Introduction and Business Overview
Table 140. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product
Table 142. Innovent Biologics, Inc. Recent Development
Table 143. Viatris Inc. (Mylan N.V.) Company Information
Table 144. Viatris Inc. (Mylan N.V.) Introduction and Business Overview
Table 145. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product
Table 147. Viatris Inc. (Mylan N.V.) Recent Development
Table 148. Lupin Company Information
Table 149. Lupin Introduction and Business Overview
Table 150. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Lupin Chronic Myeloid Leukemia Treatment Product
Table 152. Lupin Recent Development
Table 153. IL-YANG PHARM CO. LTD. Company Information
Table 154. IL-YANG PHARM CO. LTD. Introduction and Business Overview
Table 155. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product
Table 157. IL-YANG PHARM CO. LTD. Recent Development
Table 158. Million Health Pharmaceuticals Company Information
Table 159. Million Health Pharmaceuticals Introduction and Business Overview
Table 160. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product
Table 162. Million Health Pharmaceuticals Recent Development
Table 163. Celon Labs Company Information
Table 164. Celon Labs Introduction and Business Overview
Table 165. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. Celon Labs Chronic Myeloid Leukemia Treatment Product
Table 167. Celon Labs Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Chronic Myeloid Leukemia Treatment Market Trends
Table 171. Chronic Myeloid Leukemia Treatment Market Drivers
Table 172. Chronic Myeloid Leukemia Treatment Market Challenges
Table 173. Chronic Myeloid Leukemia Treatment Market Restraints
Table 174. Chronic Myeloid Leukemia Treatment Distributors List
Table 175. Chronic Myeloid Leukemia Treatment Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Myeloid Leukemia Treatment Product Picture
Figure 2. Global Chronic Myeloid Leukemia Treatment Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Chronic Myeloid Leukemia Treatment Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Chronic Myeloid Leukemia Treatment Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Tablet
Figure 6. Global Tablet Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Solution
Figure 8. Global Solution Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Capsule
Figure 10. Global Capsule Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type in 2022 & 2034
Figure 13. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type in 2022
Figure 14. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type in 2022
Figure 15. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type in 2022
Figure 16. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type in 2022
Figure 19. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Myeloid Leukemia Treatment Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Myeloid Leukemia Treatment Revenue in 2022
Figure 25. Chronic Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital Pharmacies
Figure 27. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Retail Pharmacies
Figure 29. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Online Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application in 2022 & 2034
Figure 34. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application in 2022
Figure 35. North America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application in 2022
Figure 36. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application in 2022
Figure 37. Europe Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application in 2022
Figure 40. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Chronic Myeloid Leukemia Treatment Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Chronic Myeloid Leukemia Treatment Manufacturing Cost Structure
Figure 45. Chronic Myeloid Leukemia Treatment Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries